COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 1554: Articles 15531-15540  | Next

An Immune Cell Atlas Reveals Dynamic COVID-19 Specific Neutrophil Programming Amendable to Dexamethasone Therapy
Sinha, S., Rosin, N., Arora, R., Labit, E., Jaffer, A., Cao, L., Farias, R., Nguyen, A. P., McDonald, B., Gillrie, M., Fritzler, M. J., Yipp, B., Biernaskie, J.
10.1101/2021.04.18.440366 — Posted: 2021-04-19
Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
Ramiro de Assis, R., Jain, A., Nakajima, R., Jasinskas, A., Khan, S., Palma, A., Parker, D. M., Chau, A., Leung, A., Christina, C., Muqolli, F., Khalil, G., Colin Escobar, J., Ventura, J., Davies, H., Albala, B., Boden-Albala, B., Schubl, S., Felgner, P. L.
10.1101/2021.04.15.440089 — Posted: 2021-04-19 Discussion: Onsite
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
Chaouat, A. E., Achdout, H., Kol, I., Berhani, O., Roi, G., Vitner, E. B., Melamed, S., Politi, B., Zahavi, E., Brizic, I., Lenac Rovis, T., Alfi, O. B., Wolf, D., Jonjic, S., Israely, T., Mandelboim, O.
10.1101/2021.04.18.440302 — Posted: 2021-04-19
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities
Kruse, T., Benz, C., Garvanska, D. H., Lindqvist, R., Mihalic, F., Coscia, F., Inturi, R., Sayadi, A., Simonetti, L., Nilsson, E., Ali, M., Kliche, J., Moliner Morro, A., Mund, A., Andersson, E., McInerney, G. M., Mann, M., Jemth, P., Davey, N. E., Overby, A. K., Nilsson, J., Ivarsson, Y.
10.1101/2021.04.19.440086 — Posted: 2021-04-19
Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases
Reyes-Sanchez, F., Basto-Abreu, A., Torres-Alvarez, R., Canto-Osorio, F., Gonzalez-Morales, R., Dyer, D., Lopez Ridaura, R., Zaragoza Jimenez, C. A., Rivera, J. A., Barrientos-Gutierrez, T.
10.1101/2021.04.12.21255346 — Posted: 2021-04-19
Assessing the Risk of Cascading COVID-19 Outbreaks from Prison-to-Prison Transfers
Parsons, T. L., Worden, L.
10.1101/2021.04.12.21255363 — Posted: 2021-04-19
How disease risk awareness modulates transmission: coupling infectious disease models with behavioral dynamics
Cascante-Vega, J., Torres-Florez, S., Cordovez, J., Santos-Vega, M.
10.1101/2021.04.13.21255395 — Posted: 2021-04-19
COVID transmission and contact tracing using WHO risk assement tool among frontline healthcare workers : Insights from a South Indian tertiary care centre
Moni, M., Kulirankal, K. G., Prasanna, P., Mary, A., Thomas, E. M., Sundaram, R. P., Babu, B., Bindu, V., Edathadathil, F., Bala, S., K V, B., Sathyapalan, D. T.
10.1101/2021.04.07.21255044 — Posted: 2021-04-19
Primary care and point-of-care testing during a pandemic: Clinician's perspectives on integrating rapid testing for COVID-19 into the primary care pathway
Kierkegaard, P., Hicks, T., Yang, Y., Lee, J., Hayward, G., Turner, P. J., Allen, A. J., Nicholson, B. D.
10.1101/2021.04.13.21255347 — Posted: 2021-04-19
Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations
Demmer, R. T., Baumgartner, B., Wiggen, T. D., Ulrich, A. K., Strickland, A. J., Naumchik, B. M., Bohn, B., Walsh, S., Smith, S., Kline, S., Stovitz, S. D., Yendell, S., Beebe, T., Hedberg, C.
10.1101/2021.04.12.21255330 — Posted: 2021-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).